Baidu
map

眼科

订阅

MedSci主页 / 所有栏目 / 眼科

Ocul Immunol Inflamm：新发病毒感染导致葡萄膜炎

2019-02-28 不详 网络

病毒感染葡萄膜炎
关注

突尼斯莫纳斯提尔大学医学院Fattouma Bourguiba大学医院眼科的Khairallah M等人近日在Ocul Immunol Inflamm杂志上发表了一项重要的综述文章，他们回顾了与眼科医生相关的特定紧急病毒感染性疾病的系统性和眼部症状，尤其是对葡萄膜炎的研究。

突尼斯莫纳斯提尔大学医学院Fattouma Bourguiba大学医院眼科的Khairallah M等人近日在Ocul Immunol Inflamm杂志上发表了一项重要的综述文章，他们回顾了与眼科医生相关的特定紧急病毒感染性疾病的系统性和眼部症状，尤其是对葡萄膜炎的研究。

虫媒病毒病是最重要的突发和复发的人类感染病原，主要发生在热带和亚热带地区。但由于气候变化、旅行和全球化，现在几乎出现在世界所有地区。虫媒病毒感染通过吸食性的节肢动物（主要是蚊子）传播给人类。引发的全身性疾病可能从无症状到危及生命。据报道，病毒性疾病相关的各种各样的眼部症状出现的越来越多，尤其是葡萄膜炎。除虫媒病毒以外的许多病毒最近也被认为是葡萄膜炎的潜在原因。

经过研究，他们认为，任何新出现的传染病，其临床诊断都是基于流行病学数据、病史、全身症状和体征以及眼部并发症等。通常通过检测血清中病毒特异性DNA，或检测抗病毒抗体可以进行确认诊断。

原文出处：

Khairallah， M.， et al.， Emerging Viral Infections Causing Anterior Uveitis. Ocul Immunol Inflamm， 2019： p. 1-10.

本文系梅斯医学（MedSci）原创编译整理，转载需授权！

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2057656, encodeId=1eaa205e656fe, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jul 15 14:27:00 CST 2019, time=2019-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454855, encodeId=67831454855c2, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sat Mar 02 14:27:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361733, encodeId=4108361e33f2, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:35:19 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361732, encodeId=d70e361e32ba, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:30:49 CST 2019, time=2019-02-28, status=1, ipAttribution=)]
    2019-07-15 柳叶一刀

    #LAM#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2057656, encodeId=1eaa205e656fe, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jul 15 14:27:00 CST 2019, time=2019-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454855, encodeId=67831454855c2, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sat Mar 02 14:27:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361733, encodeId=4108361e33f2, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:35:19 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361732, encodeId=d70e361e32ba, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:30:49 CST 2019, time=2019-02-28, status=1, ipAttribution=)]
    2019-03-02 xiaoyeshuang

    #NFL#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2057656, encodeId=1eaa205e656fe, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jul 15 14:27:00 CST 2019, time=2019-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454855, encodeId=67831454855c2, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sat Mar 02 14:27:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361733, encodeId=4108361e33f2, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:35:19 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361732, encodeId=d70e361e32ba, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:30:49 CST 2019, time=2019-02-28, status=1, ipAttribution=)]
    2019-02-28 清风拂面

    谢谢分享学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2057656, encodeId=1eaa205e656fe, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jul 15 14:27:00 CST 2019, time=2019-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454855, encodeId=67831454855c2, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sat Mar 02 14:27:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361733, encodeId=4108361e33f2, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:35:19 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361732, encodeId=d70e361e32ba, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Feb 28 23:30:49 CST 2019, time=2019-02-28, status=1, ipAttribution=)]
    2019-02-28 清风拂面

    谢谢分享学习

    0

相关资讯

Cell Rep：病毒学国家重点实验室刘昱课题组在抗病毒天然免疫方面取得新进展

近日，病毒学国家重点实验室刘昱教授课题组在国际学术期刊Cell Reports上在线发表了最新研究成果，论文题为“TMED2 potentiates cellular IFN responses to DNA viruses by reinforcing MITA dimerization and facilitating its trafficking”。

Cell：揭示流感病毒如何成功地从宿主细胞中逃逸出来

几十年来，科学家们已知道人体内的流感病毒与实验室中培养的流感病毒有很大不同。一种常用的研究流感病毒的方法就是将荧光蛋白与组成流感病毒的蛋白融合在一起。但是这些荧光蛋白与流感蛋白具有大约相同的大小，引入如此相对较大的融合蛋白到流感病毒中会引发病毒紊乱。

J Virol：盐霉素可通过干扰核内体的酸化和病毒基质蛋白2的功能抑制流感病毒感染

流感病毒是造成人和动物呼吸道感染的重要病原，该病毒传染性强，且容易发生变异导致感染人或动物的高死亡率。金刚烷胺、奥司他韦及扎那米韦是目前较为常用并能有效抑制流感病毒的药物，但由于流感病毒毒株容易发生变异，造成这些药物的有效性在不断减弱。

Small：研究揭示发热伴血小板减少综合征病毒入侵细胞的精细动态过程

发热伴血小板减少综合征病毒(SFTSV)是近年来在我国发现的蜱传、高致病性的新型布尼亚病毒，其病死率高达30%。目前，关于SFTSV的感染和致病机制尚不清楚，也缺乏有效的疫苗和药物对相关疾病进行防控和治疗。

Cancer Gene Ther：去势抵抗性前列腺癌细胞中的基因疗法研究

前列腺癌是全球范围内男性的第二大癌症。晚期阶段的前列腺癌患者通常通过雄激素阻断疗法（ADT）来治疗。然而，随着疾病的恶化，常常会发展成为不可治愈的去势抵抗性前列腺癌（CRPC）。JC型多瘤病毒（JCPyV）是一种人类DNA病毒。它的类病毒颗粒（VLPs）展现出了与原生病毒相似的趋向性，并且具有将外源基因转化进靶细胞进行表达的能力。研究人员在前列腺细胞中检测到了JCPyV；因此，前列腺癌细胞可能对J

J Aller Cl Imm-Pract：病毒引起的严重哮喘急性发作成年患者血清IgG浓度的意义

由此可见，当哮喘急性发作时血清IgG显著降低与病毒样本阳性相关。血清IgG浓度较低的患者需要更长的住院时间和更长的类固醇疗程。

Baidu
map
Baidu
map
Baidu
map